BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10410230)

  • 1. [The place of the new quinolones in the guidelines on the treatment of community-acquired pneumonia].
    Dorca J
    Arch Bronconeumol; 1999 May; 35 Suppl 3():77-80. PubMed ID: 10410230
    [No Abstract]   [Full Text] [Related]  

  • 2. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 3. [New quinolones for the treatment of community-acquired pneumonia--pro].
    Zimmerli S
    Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of quinolones in the treatment of community acquired pneumonia].
    Garau J
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antibacterial therapy of community-acquired pneumonia].
    Khveshchuk PF; Rakov AL; Sinopal'nikov AI; Rudakova AV
    Voen Med Zh; 1999 Jan; 320(1):25-36. PubMed ID: 10200622
    [No Abstract]   [Full Text] [Related]  

  • 6. [Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines].
    Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):381-6. PubMed ID: 12661455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug not considered a first-line agent.
    Lexchin J
    Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience of levofloxacin in community acquired pneumonia].
    Arancibia F; Maldonado A; Torres A
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():14-8. PubMed ID: 10563105
    [No Abstract]   [Full Text] [Related]  

  • 9. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N; Nendaz M
    Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer fluoroquinolones and the management of respiratory tract infections.
    Karchmer AW
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
    [No Abstract]   [Full Text] [Related]  

  • 12. Journal of Managed Care Pharmacy. START (Stewardship Tactics for Antimicrobial Resistance Trends). Introduction.
    Rodvold KA
    J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S3-4. PubMed ID: 19358369
    [No Abstract]   [Full Text] [Related]  

  • 13. [New quinolones].
    Bello Dronda S
    Arch Bronconeumol; 1999 May; 35 Suppl 3():70-6. PubMed ID: 10410229
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for treatment of community-acquired pneumonia.
    Kim MK; Nightingale C; Quintiliani R
    Conn Med; 2001 Aug; 65(8):473-5. PubMed ID: 11550446
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the management of community-acquired pneumonia in children.
    Lee PI; Chiu CH; Chen PY; Lee CY; Lin TY;
    Acta Paediatr Taiwan; 2007; 48(4):167-80. PubMed ID: 18265536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Accordance to guidelines for community acquired pneumonia in Europe and in the world].
    Giejło M; Szmidt M
    Pneumonol Alergol Pol; 2007; 75(2):173-9. PubMed ID: 17973225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of lower respiratory tract infections in immunocompetent adults (community-acquired pneumonia and acute exacerbation of chronic obstructive pulmonary disease): the challenge of a new consensus conference].
    Chidiac C
    Med Mal Infect; 2006 Jan; 36(1):1-3. PubMed ID: 16413722
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolones for respiratory infections: too valuable to overuse.
    Williams JH
    Chest; 2001 Dec; 120(6):1771-5. PubMed ID: 11742900
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs of choice for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
    [No Abstract]   [Full Text] [Related]  

  • 20. Community-acquired pneumonia.
    Torres A
    Semin Respir Crit Care Med; 2009 Apr; 30(2):125-6. PubMed ID: 19296411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.